← Back to Analyst Consensus 
NDRA Buy
ENDRA Life Sciences Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 1, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 8, 2025 | Ascendiant Capital | maintain | Buy → Buy | $30 | 38% |
| Sep 22, 2025 | Ascendiant Capital | maintain | Buy → Buy | $38 | 38% |
| May 30, 2025 | Ascendiant Capital | maintain | Buy → Buy | $46 | 38% |
| Apr 21, 2025 | Ascendiant Capital | maintain | Buy → Buy | $50 | 38% |
| Jun 7, 2024 | Ascendiant Capital | maintain | Buy → Buy | $8 | 38% |
| Mar 31, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $9 | 44% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days